Kidney Transplant
📧 Sign up to get email alerts when something new happens for Kidney Transplant.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation [Phase 4]
Phase 4 trial updating safety and immunogenicity of Zostavax vaccine in patients undergoing living donor kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen [Phase 4]
Phase 4 clinical trial update investigating risk factors in Chinese kidney transplant recipients receiving an MPA-based immunosuppressive re…
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Remote Ischemic Preconditioning Living Donor Renal Transplant Protocol [NA]
A clinical trial update for a renal transplant protocol using remote ischemic preconditioning has terminated; results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine [Phase 2]
Phase 2 clinical trial evaluating phenotypic precision medicine to optimize immunosuppression dosing in liver and kidney transplant recipien…
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: A Cohort Study of Operationally Tolerant Allograft Recipients
A cohort study on operational tolerance in kidney and liver transplant recipients has terminated; results posted in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-08-11FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil hydrochloride) submitted by Genentech, authorizing an update to …
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Mycophenolate mofetil submitted by Strides Pharma Science Limited. The approval covers the gener…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients [Phase 4]
Phase 4 trial updating the interaction of apixaban with cyclosporine or tacrolimus in transplant recipients, focusing on pharmacokinetics.
-
FDA approval · 2021-04-21FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s supplemental application for Mycophenolate mofetil, a generic immunosuppressant used to preven…
-
FDA approval · 2021-03-12FDA Approved: SIROLIMUS — Original Application (Ascend Laboratories, LLC)
FDA approves the original (generic) application for sirolimus from Ascend Laboratories, authorizing its marketing as an immunosuppressant. T…
-
FDA approval · 2021-01-15FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Myfortic (mycophenolic acid) submitted by Novartis Pharmaceuticals Corporation. The approval typ…
-
FDA approval · 2021-01-15FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for mycophenolate mofetil (generic) submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients [Phase 4]
Phase 4 trial updating efficacy and safety of once-daily tacrolimus in kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer [Phase 4]
Phase 4 pharmacokinetic study evaluating tacrolimus and mycophenolate mofetil in kidney transplant recipients with hyperkalemia treated with…
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day. [Phase 4]
Phase 4 trial updating pharmacodynamic conversion from twice-daily tacrolimus to once-daily LCP Tacro in stable renal transplant patients; c…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM) [Phase 4]
Phase 4 study evaluating tacrolimus in kidney transplant recipients is underway but status is unknown.
-
CLINICAL_TRIALS withdrawal · 2019-12-16Clinical Trial Update: Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant Recipients [Phase 4]
Phase 4 trial evaluating sirolimus and maraviroc on CCR5 expression and HIV-1 reservoir in HIV-infected kidney transplant recipients has bee…
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant [Phase 4]
Phase 4 trial evaluating the impact of Everolimus on HIV persistence after kidney or liver transplant; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Basiliximab vs Low-dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients [Phase 4]
Phase 4 trial comparing Basiliximab versus low-dose Thymoglobulin induction therapy in low-risk kidney transplant patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients [Phase 4]
Phase 4 trial updating the pharmacokinetic interaction between everolimus and tacrolimus in renal transplant patients.
-
FDA approval · 2019-06-11FDA Approved: ASTAGRAF XL — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for ASTAGRAF XL (tacrolimus extended-release capsules) submitted by Astellas Pharma US, Inc., approv…
-
FDA approval · 2019-02-27FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil hydrochloride) submitted by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Esomeprazole or Pantoprazole in Renal Transplantation [NA]
This clinical trial update reports completion of a study comparing esomeprazole and pantoprazole in kidney transplant recipients. The trial …
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation [Phase 4]
Phase 4 clinical trial comparing antithymocyte globulin with azathioprine to basiliximab with mycophenolate mofetil in living donor kidney t…
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: CCFZ533X2201 - PoC Study in de Novo Renal Transplantation [Phase 1, Phase 2]
Phase 1/2 PoC study in de novo kidney transplantation by Novartis (CCFZ533X2201) has completed with results posted in 2018.